Moreover, in light of the recent finding that intranasal insulin improves cognition in early AD patients [39], and given insulin's beneficial effects on learning and memory [1], it may be overly simplistic to assume that IDE's role in AD pathogenesis is limited to its predicted effects on Aβ alone. Here, INS is linked to Alzheimer disease.